Impact of oxypurinol in patients with symptomatic heart failure: results of the OPT-CHF study
Objectives: This study evaluated whether a xanthine oxidase (XO) inhibitor, oxypurinol,
produces clinical benefits in patients with New York Heart Association functional class III to …
produces clinical benefits in patients with New York Heart Association functional class III to …
The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study
HE Cingolani, JA Plastino, EM Escudero… - Journal of cardiac …, 2006 - Elsevier
BACKGROUND: Reactive oxygen species (ROS) have been linked to hypertrophy,
remodeling and abnormal excitation-contraction coupling. Previous data demonstrated that …
remodeling and abnormal excitation-contraction coupling. Previous data demonstrated that …
Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study
MM Givertz, KJ Anstrom, MM Redfield, A Deswal… - Circulation, 2015 - Am Heart Assoc
Background—Oxidative stress may contribute to heart failure (HF) progression. Inhibiting
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and …
xanthine oxidase in hyperuricemic HF patients may improve outcomes. Methods and …
Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study
K Ogino, M Kato, Y Furuse, Y Kinugasa… - Circulation: Heart …, 2010 - Am Heart Assoc
Background—Hyperuricemia is common in chronic heart failure (CHF), and it is a strong
independent marker of prognosis. Upregulated xanthine oxidase (XO) activity and impaired …
independent marker of prognosis. Upregulated xanthine oxidase (XO) activity and impaired …
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure
AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - American heart …, 2010 - Elsevier
BACKGROUND: Previous studies have not extensively examined the association of
hyperuricemia and adverse outcomes in systolic heart failure (HF) in relation to xanthine …
hyperuricemia and adverse outcomes in systolic heart failure (HF) in relation to xanthine …
[HTML][HTML] Uric acid is a biomarker of oxidative stress in the failing heart: lessons learned from trials with allopurinol and SGLT2 inhibitors
M Packer - Journal of cardiac failure, 2020 - Elsevier
Hyperuricemia increases the risk of heart failure, and higher levels of serum uric acid are
seen in patients who have worse ventricular function, functional capacity, and prognosis …
seen in patients who have worse ventricular function, functional capacity, and prognosis …
Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival
OBJECTIVE: Uric acid (UA) levels are frequently increased in patients with heart failure (HF),
and may be an indicator of a poor prognosis and an innovative target for treatment. We …
and may be an indicator of a poor prognosis and an innovative target for treatment. We …
Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition
Increasing evidence suggests that serum uric acid (UA), a product of xanthine oxidase (XO),
may be a useful marker for metabolic, hemodynamic, and functional staging in heart failure …
may be a useful marker for metabolic, hemodynamic, and functional staging in heart failure …
Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin …
M Vaduganathan, SJ Greene, AP Ambrosy… - The American Journal of …, 2014 - Elsevier
We investigated the clinical profiles associated with serum uric acid (sUA) levels in a large
cohort of patients hospitalized for worsening chronic heart failure with ejection fraction …
cohort of patients hospitalized for worsening chronic heart failure with ejection fraction …
Uric acid and xanthine oxidase in heart failure—Emerging data and therapeutic implications
W Doehner, EA Jankowska, J Springer… - International journal of …, 2016 - Elsevier
The role of hyperuricaemia as cardiovascular risk factor has exhaustingly been debated for
decades. While the association of elevated uric acid (UA) levels with increased mortality risk …
decades. While the association of elevated uric acid (UA) levels with increased mortality risk …
相关搜索
- heart failure allopurinol use
- heart failure oxypurinol in patients
- opt chf oxypurinol in patients
- heart failure opt chf
- heart failure paragon hf
- heart failure mortality and morbidity
- heart failure uric acid
- heart failure risk markers
- heart failure xanthine oxidase
- heart failure cardiovascular outcomes
- heart failure treatment with benzbromarone
- heart failure therapeutic implications
- heart failure ejection fraction
- heart failure benzbromarone in patients
- heart failure acid level